| 发明名称 |
HETEROCYCLIC COMPOUND |
| 摘要 |
The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action.;The present invention relates to a compound represented by the formula;;wherein each symbol is as defined in the specification, or a salt thereof. |
| 申请公布号 |
US2015045349(A1) |
申请公布日期 |
2015.02.12 |
| 申请号 |
US201314379343 |
申请日期 |
2013.02.19 |
| 申请人 |
Takeda Pharmaceutical Company Limited |
发明人 |
Nagamiya Hiroyuki;Yoshida Masato;Seto Masaki;Marui Shogo;Oda Tsuneo;Ishichi Yuji;Suzuki Hideo;Kusumoto Tomokazu;Yogo Takatoshi;Rhim Chul Yun;Yoon Cheolhwan;Lee Gil Nam;Kang Hyun Bin;Kim Kwang Ok;Jeon Hye Sun |
| 分类号 |
C07D471/04 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A compound represented by the formula (I): wherein R1 is an optionally substituted C1-6 alkyl group or an optionally substituted cyclic group; R2 is a hydrogen atom or a cyano group; and R3 is a hydrogen atom, a halogen atom, a 5-membered aromatic ring group optionally having one substituent, or an optionally substituted 6- to 12-membered aromatic ring group, or a salt thereof. |
| 地址 |
Osaka JP |
